+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Moderate To Severe Acne - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Acne - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Neuropathic Pruritus & Postburn Itch - Pipeline Insight, 2025 - Product Thumbnail Image

Neuropathic Pruritus & Postburn Itch - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Obese Patients With Schizophrenia - Pipeline Insight, 2025 - Product Thumbnail Image

Obese Patients With Schizophrenia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
PD-1 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Primary Mitochondrial Myopathies - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Mitochondrial Myopathies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Punctate Epitheliopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Punctate Epitheliopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Central Retinal Venous Occlusion - Pipeline Insight, 2025 - Product Thumbnail Image

Central Retinal Venous Occlusion - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chemotherapy-Induced Hearing Loss - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy-Induced Hearing Loss - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Somatostatinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Somatostatinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Cutaneous Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Cutaneous Ulcers - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025 - Product Thumbnail Image

Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acute Radiation Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Radiation Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Granulomatosis With Polyangiitis - Pipeline Insight, 2025 - Product Thumbnail Image

Granulomatosis With Polyangiitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Interstitial Lung Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Lung Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
CLN1 - Pipeline Insight, 2025 - Product Thumbnail Image

CLN1 - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Atopic Keratoconjuctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Atopic Keratoconjuctivitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Community Acquired Uncomplicated UTI - Pipeline Insight, 2025 - Product Thumbnail Image

Community Acquired Uncomplicated UTI - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Inducible Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Inducible Urticaria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Congenital Ichthyosis - Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Ichthyosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Ebola Fever - Pipeline Insight, 2025 - Product Thumbnail Image

Ebola Fever - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more